American Research & Management Co. Biogen Inc. Transaction History

American Research & Management Co.

$362 Million
Q3 2022

A detailed history of American Research & Management Co. transactions in Biogen Inc. stock. As of the latest transaction made, American Research & Management Co. holds 3,658 shares of BIIB stock, worth $821,623. This represents 0.27% of its overall portfolio holdings.

Number of Shares

3,658

Previous 3,993 8.39%

Holding current value

$821,623

Previous $814,000 20.02%

% of portfolio

0.27%

Previous 0.21%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	SELL	$194.69 - $268.46 $65,221 - $89,934	-335 Reduced 8.39%	3,658 $977,000
Q2 2022 Jul 22, 2022	SELL	$187.54 - $223.02 $111,773 - $132,919	-596 Reduced 12.99%	3,993 $814,000
Q1 2022 Apr 21, 2022	SELL	$193.77 - $244.14 $68,788 - $86,669	-355 Reduced 7.18%	4,589 $966,000
Q4 2021 Jan 28, 2022	SELL	$223.92 - $287.77 $245,192 - $315,108	-1,095 Reduced 18.13%	4,944 $1.19 Million
Q3 2021 Oct 28, 2021	SELL	$282.99 - $369.05 $116,025 - $151,310	-410 Reduced 6.36%	6,039 $1.71 Million

Q2 2021 Jul 16, 2021	SELL	$259.0 - $414.71 $52,318 - $83,771	-202 Reduced 3.04%	6,449 $2.23 Million
Q1 2021 Apr 06, 2021	SELL	$242.95 - $284.63 $34,013 - $39,848	-140 Reduced 2.06%	6,651 $1.86 Million
Q4 2020 Jan 28, 2021	SELL	$236.26 - $355.63 $23,626 - $35,563	-100 Reduced 1.45%	6,791 $1.66 Million
Q3 2020 Oct 29, 2020	SELL	$264.77 - $305.71 $10,326 - $11,922	-39 Reduced 0.56%	6,891 $1.96 Million
Q1 2020 Apr 28, 2020	SELL	$268.85 - $341.04 $26,885 - $34,104	-100 Reduced 1.42%	6,930 $2.19 Million
Q4 2019 Jan 17, 2020	SELL	$220.06 - $304.07 $379,603 - $524,520	-1,725 Reduced 19.7%	7,030 $2.09 Million
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $285,933 - $320,702	-1,315 Reduced 13.06%	8,755 $2.04 Million
Q2 2019 Jul 18, 2019	SELL	$219.29 - $241.72 $70,172 - $77,350	-320 Reduced 3.08%	10,070 $2.36 Million
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $6,962 - $8,818	-25 Reduced 0.24%	10,390 $3.13 Million
Q3 2018 Oct 04, 2018	BUY	$293.51 - $383.83 $17,610 - $23,029	60 Added 0.58%	10,415 $3.68 Million
Q2 2018 Jul 25, 2018	BUY	$257.52 - $306.91 $294,860 - $351,411	1,145 Added 12.43%	10,355 $3.01 Million
Q1 2018 Apr 19, 2018	BUY	$260.13 - $367.91 $28,614 - $40,470	110 Added 1.21%	9,210 $2.52 Million
Q4 2017 Feb 08, 2018	BUY	$307.64 - $344.58 $19,996 - $22,397	65 Added 0.72%	9,100 $2.9 Million
Q3 2017 Oct 17, 2017	BUY	$281.15 - $329.69 $2.54 Million - $2.98 Million	9,035	9,035 $2.83 Million

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.

Account

American Research & Management Co. Biogen Inc. Transaction History